Peter Svennilson
InvestorManaging Partner at The Column Group
San Francisco, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Peter
1,736 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.
About
Peter Svennilson led Aragon to a ~$1B J&J sale and chaired Seragon to a Genentech/Roche exit; as an Institute for Advanced Study Trustee he links theoretical science with translational creation.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Experience
- The Column GroupManaging Partner and Foundercurrent2007 — presentSan Francisco Bay Area
- Three Crowns CapitalManaging Partner and Founder1996 — 2006
Deals · 3
Circle PharmaBoard seat
via The Column Group · filed Jun 2021 · $66.3M raise
Constellation PharmaBoard seat
via The Column Group · filed Apr 2018 · $100M raise
Ngm BiopharmaceuticalsBoard seat
via The Column Group · filed Feb 2015 · $60M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Aragon PharmaceuticalsCarmot TherapeuticsGritstone BioRemix Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at The Column Group
Frequently asked questions
- Who is Peter Svennilson?
- Peter Svennilson led Aragon to a ~$1B J&J sale and chaired Seragon to a Genentech/Roche exit; as an Institute for Advanced Study Trustee he links theoretical science with translational creation.
- Where does Peter Svennilson work?
- Peter Svennilson is Managing Partner at The Column Group.
- What does Peter Svennilson invest in?
- Peter Svennilson invests in Biotech, Healthtech.
- What check size does Peter Svennilson write?
- Peter Svennilson typically writes checks of $100K – $5M.
- What boards does Peter Svennilson sit on?
- Peter Svennilson holds tracked board seats at Circle Pharma, Constellation Pharma, Ngm Biopharmaceuticals.
- What companies has Peter Svennilson invested in?
- Investments tracked here include Aragon Pharmaceuticals, Carmot Therapeutics, Circle Pharma, Gritstone Bio, Ngm Biopharmaceuticals, Remix Therapeutics.
- Where did Peter Svennilson go to school?
- Peter Svennilson studied at Stockholm School of Economics (Master of Business Administration (MBA), Business Administration and Management, General); London Business School (Studies at MBA Program); INSEAD (Studies at MBA Program).
Same school
Also attended Stockholm School of Economics342
+ 336 more
Also attended London Business School911
+ 905 more
